Nicotinic antagonists in the treatment of nerve agent intoxication

Journal of the Royal Society of Medicine

Volumn 98, Issue 3, 2005, Pages 114-115

  Sheridan, Robert D ^a   Smith, Andrew P ^a   Turner, Simon R ^a   Tattersall, John E H ^a  

^a DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; GALLAMINE; METHYLPHOSPHONOTHIOIC ACID S (2 DIISOPROPYLAMINOETHYL) O ETHYL ESTER; MUSCARINIC RECEPTOR; NERVE GAS; NEUROMUSCULAR BLOCKING AGENT; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; ORGANOPHOSPHORUS COMPOUND; PANCURONIUM; PRALIDOXIME; SARIN; SOMAN; TABUN; ACETYLCHOLINE; CENTRAL NERVOUS SYSTEM AGENTS; CHOLINERGIC RECEPTOR;

ACUTE TOXICITY; BRADYCARDIA; BRONCHOSPASM; EXPOSURE; FASCICULATION; HUMAN; HYPERTENSION; INTOXICATION; MUSCLE WEAKNESS; NEUROMUSCULAR SYNAPSE; NEUROTRANSMISSION; NONHUMAN; REVIEW; SWEATING; SYMPATHETIC GANGLION; TACHYCARDIA; METABOLISM;

ACETYLCHOLINE; CENTRAL NERVOUS SYSTEM AGENTS; HUMANS; NICOTINIC ANTAGONISTS; ORGANOPHOSPHORUS COMPOUNDS; RECEPTORS, CHOLINERGIC;

EID: 15044347898     PISSN: 01410768     EISSN: None     Source Type: Journal    
DOI: 10.1258/jrsm.98.3.114     Document Type: Review

References (17)

1. Brown MA, Brix KA. Review of health consequences from high-, intermediate- and low-level exposure to organophosphorus nerve agents. J Appl Toxicol 1998;18:393-408
2. Smythies J, Golomb B. Nerve gas antidotes. J R Soc Med 2004;97:32
3. Scheffer IE, Berkovic SF. Genetics of the epilepsies. Curr Opin Pediatr 2000;12:536-42
4. Shih T, McDonaugh JH Jr, Koplovitz I. Anticonvulsants for soman-induced seizure activity. J Biomed Sci 1999;6:86-96
5. Harrison PK, Sheridan RD, Green AC, Scott IR, Tattersall JEH. A guinea pig hippocampal slice model of organophosphate-induced seizure activity. J Pharmacol Exp Ther 2004;310:678-86
6. Hayward IJ, Wall HG, Jaax NK, Wade JV, Marlow DD, Nold JB. Decreased brain pathology in organophosphate-exposed rhesus monkeys following benzodiazepine therapy. J Neurol Sci 1990;98; 99-106
7. Morita H, Yanagisawa N, Nakajima T, et al. Sarin poisoning in Matsumoto, Japan. Lancet 1995;346:290-3
8. Nozaki H, Alkawa N, Fujishima S, et al. A case of VX poisoning and the difference from sarin. Lancet 1995;346:698-9
9. Sungur M, Güven M. Intensive care management of organophosphate insecticide poisoning. Crit Care 2001;6:211-15
10. Karki P, Ansari JA, Bhandary S, Koirala S. Cardiac and electrocardiographical manifestations of acute organophosphate poisoning. Singapore Med J 2004;45:385-9
11. Suzuki T, Morita H, Ono K, Mackawa K, Nagai R, Yazald Y. Sarin poisoning in Tokyo subway. Lancet 1995;345:980
12. Taylor P. Agents acting at the neuromuscular junction and autonomic ganglia. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW & Goodman Gilman A, eds. The Pharmacological Basis of Therapeutics, 9th edn. New York: McGraw-Hill, 1996:177-97
13. Alkondon M, Rao KS, Albuquerque EX. Acetylcholinesterase reactivators modify the functional properties of the nicotinic acetylcholine receptor ion channel. J Pharmacol Exp Ther 1988;245:543-56
14. Tattersall JEH. Ion channel blockade by oximes and recovery of diaphragm muscle from soman poisoning in vitro. Br J Pharmacol 1993;108:1006-15
15. Smith AP, Muir AW. Antidotal action of the oxime HS6 at the soman poisoned neuromuscular junction of the rat and guinea-pig. J Pharm Pharmacol 1977;29:762-4
16. Alkondon M, Albuquerque E. The nonoxime bispyridinium compound SAD-128 alters the kinetic properties of the nicotinic acetylcholine receptor ion channel: a possible mechanism for antidotal effects. J Pharmacol Exp Ther 1989;250:842-52
17. Buckley NA, Karalliedde L, Dawson A, Senenayake N, Eddleston M. Where is the evidence for treatments used in pesticide poisoning? Is clinical toxicology fiddling while the developing world burns? J Toxicol 2004;42:113-16